← World Watch
Disruptionother · September 24, 2026
Eli Lilly breaks ground on $6.5B Houston manufacturing plant
A new pharmaceutical manufacturing plant is being started, implying future added drug production capacity in Houston.
Source →The trace
How it reaches your house.
Starting from Catalent (acquired by Novo Nordisk), we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Eli Lilly and Company →supply upUnited Therapeutics CorporationUTHR
United Therapeutics says it relies entirely on Lilly to manufacture Adcirca, so Lilly's added manufacturing capacity should ease the single-source bottleneck and improve supply availability.
46% confidence
Where it lands
What you buy, and what you own.
Goods you buy
No consumer goods on this path.
In the MyPRIA app, this is checked against your own holdings.